Microbix is a profitable and growing, publicly-traded (TSX, OTCQX), award-winning, Ontario-headquartered, world leader in the development and manufacture of specific biotechnology solutions for human health. The company has over 110 skilled employees based in Mississauga. It is currently ISO9001- and ISO13485 (Medical Device)-accredited, has a Pathogen and Toxin license issued by the Public Health Agency of Canada and a Medical Device Establish License (MDEL) from Health Canada. The company’s current 34,000 ft2 campus comprises R&D, manufacturing, and testing facilities.
The company makes a range of critical materials for the global diagnostics industry, notably infectious disease antigens for diagnostic immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, enable new test validation, or ensure the optimum accuracy of testing in clinical diagnostics laboratories. Microbix’s antigens enable the antibody tests of over 120 international diagnostics companies, while its QAPs are sold to globally to clinical laboratory accreditation organizations, diagnostics companies, and clinical laboratories.